{
  "compound_id": "DB01250",
  "compound_name": "Olsalazine",
  "compound_percentile": 0.852941176470588,
  "disease_id": "DOID:2531",
  "disease_name": "hematologic cancer",
  "disease_percentile": 0.61443433029909,
  "metapath_contribution": {
    "CbGaD": 0.4547312494288915,
    "CbGbCtD": 0.3795719934491581,
    "CbGdCrCtD": 0.002864327231400032,
    "CbGeAlD": 0.04012157515450727,
    "CbGpPWpGaD": 0.1200526687654452,
    "CrCbGaD": 0.002658185970597909
  },
  "n_trials": 0.0,
  "prediction": 0.00284156022890835,
  "status": 0,
  "training_prediction": 0.0252879381906547
}